IMMUNOMETABOLIX

As the CEO of ImmunoMetabolix, Vladimir combines the two for an opportunity to provide extraordinary outcomes for patients, caregivers, providers, advocacy groups, payers, and overall stakeholders. ImmunoMetabolix is a clinical-stage biotechnology company focused on applying a novel engineering approach to develop metabolically-fit immunotherapies for patients with cancer, autoimmune, and inflammatory diseases... As the founder of ImmunoMetabolix, Abhinav aims to utilize the formulations developed to modulate the metabolism of immune system to resolve immune related disorders in patients. ImmunoMetabolix is a clinical-stage biotechnology company focused on applying a novel engineering approach to develop metabolically-fit immunotherapies for patients with cancer, autoimmune, and inflammatory diseases... Our Vision is to lead in the development and commercialization of novel immunometabolic therapies for the benefit of patients with significant unmet medical needs.

Primary location: Bridgewater United States